April 15, 2021 -- Thermo Fisher Scientific announced it will acquire clinical research services company PPD for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt.
PPD has more than 26,000 colleagues operating in nearly 50 countries. In 2020, the company generated revenue of $4.7 billion. Upon close of the transaction, PPD will become part of Thermo Fisher's Laboratory Products and Services Segment.
The transaction is expected to be completed by the end of 2021, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
